REVIEW
Published on 31 Mar 2022
Rapidly Evolving Landscape and Future Horizons in Hepatocellular Carcinoma in the Era of Immuno-Oncology
doi 10.3389/fonc.2022.821903
- 2,953 views
- 4 citations
- Frontiers in Oncology
- Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
- Research Topics
- Treatment update and Future directions in the era of precision and immuno-oncology for Cholangiocarcinoma and Hepatocellular Carcinoma
Treatment update and Future directions in the era of precision and immuno-oncology for Cholangiocarcinoma and Hepatocellular Carcinoma
14k
Total downloads
38k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 11 Mar 2022
IL-6 Promoter Hypomethylation Acts As a Diagnostic Biomarker in Hepatitis B Virus-Associated Hepatocellular Carcinoma
doi 10.3389/fonc.2022.746643
- 1,713 views
- 8 citations
ORIGINAL RESEARCH
Published on 22 Feb 2022
Associations of Racial and Ethnic Category, Age, Comorbidities, and Socioeconomic Factors on Concordance to NCCN Guidelines for Patients With High-Risk Biliary Tract Cancers After Surgery
doi 10.3389/fonc.2022.771688
- 2,342 views
- 6 citations
ORIGINAL RESEARCH
Published on 11 Feb 2022
Correlation Between Adjuvant Chemotherapy Regimen, Recurrence Pattern and Prognosis of Cholangiocarcinoma After Radical Surgery
doi 10.3389/fonc.2022.695228
- 1,239 views
- 5 citations
SYSTEMATIC REVIEW
Published on 22 Dec 2021
Meta-Analysis of Postoperative Adjuvant Hepatic Artery Infusion Chemotherapy Versus Surgical Resection Alone for Hepatocellular Carcinoma
doi 10.3389/fonc.2021.720079
- 2,131 views
- 17 citations
ORIGINAL RESEARCH
Published on 19 Nov 2021
A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients
doi 10.3389/fonc.2021.766072
- 1,667 views
- 3 citations
REVIEW
Published on 15 Nov 2021
Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
doi 10.3389/fonc.2021.768009
- 10,053 views
- 32 citations
REVIEW
Published on 22 Oct 2021
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Progresses and Challenges
doi 10.3389/fonc.2021.737497
- 4,446 views
- 26 citations
ORIGINAL RESEARCH
Published on 19 Oct 2021
Camrelizumab Plus Sorafenib Versus Sorafenib Monotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Analysis
doi 10.3389/fonc.2021.694409
- 2,078 views
- 18 citations
